Sfoglia per Autore
Core binding factor acute myeloid leukaemia and c-KIT mutations
2013-01-01 Ludovica Riera; Filippo Marmont; Daniela Toppino; Chiara Frairia; Francesca Sismondi; Ernesta Audisio; Cristiana Di Bello; Stefano D'Ardia; Paola Francia Di Celle; Emanuela Messa; Giorgio Inghirami; Umberto Vitolo; Achille Pich
Core binding factor acute myeloid leukemia and c-kit mutations
2012-01-01 Pich A; Riera L; Frairia C; Toppino D; Audisio E; Sismondi F; D’Ardia S; Di Bello C; Messa E; Francia di Celle P; Marmont F; Inghirami G; Vitolo U
JAK2V617F mutation and allele burden are associated with distinct clinical and morphological subtypes in patients with essential thrombocythaemia
2012-01-01 Pich A; Riera L; Beggiato E; Nicolino B; Godio L; Campisi P; Sismondi F; Francia di Celle P.
JAK2V617F mutation and allele burden in patients with essential thrombocythemia
2011-01-01 PICH A; RIERA L; BEGGIATO E; NICOLINO B; GODIO L; CAMPISI P; FRANCIA DI CELLE P.
Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects.
2011-01-01 Riera L; Lasorsa E; Bonello L; Sismondi F; Tondat F; Di Bello C; Francia di Celle P; Chiarle R; Godio L; Pich A; Facchetti F; Ponzoni M; Marmont F; Zanon C; Bardelli A; Inghirami G.
JAK2V617F MUTATIONAL STATUS IS ASSOCIATED WITH DIFFERENT PHENOTYPES IN ESSENTIAL TROMBOCYTHEMIA
2010-01-01 Pich A; Riera L; Godio L; Sismondi F; Francia di Celle P
Unveiling the pathogenetic role of Stat3 in human lymphoma
2010-01-01 Piva R; Pellegrino E; Ferreri C; Cuccuru G; Boccalatte F; Compagno M; Riera L; Cantarella D; Medico E; Agnelli L; Neri A;Di Cunto F; Provero P; Inghirami G
JAK2V617F mutation and allele burden: correlation with morphologic and clinical features and response to therapy in patients with essential thrombocytemia.
2010-01-01 L. Riera L; Sismondi F; Tondat F; Beggiato E; Schinco P; Nicolino B; Godio L; Francia di Celle P; Pich A.
Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth.
2010-01-01 Riera L; Lasorsa E; Ambrogio C; Surrenti N; Voena C; Chiarle R.
Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene
2010-01-01 Barbieri I; Quaglino E; Maritano D; Pannellini T; Riera L; Cavallo F; Forni G; Musiani P; Chiarle R; Poli V.
NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells
2009-01-01 Ambrogio C; Martinengo C; Voena C; Tondat F; Riera L; di Celle PF; Inghirami G; Chiarle R.
The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL
2009-01-01 Boccalatte FE; Voena C; Riganti C; Bosia A; D'Amico L; Riera L; Cheng M; Ruggeri B; Jensen ON; Goss VL; Lee K; Nardone J; Rush J; Polakiewicz RD; Comb MJ; Chiarle R; Inghirami G
JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia
2009-01-01 Pich A; Riera L; Sismondi F; Godio L; Davico Bonino L; Marmont F; Francia di Celle P.
JAK2 V617F activating mutation in chronic myelomonocytic leukemia
2008-01-01 PICH A; RIERA L; SISMONDI F; GODIO L; DAVICO BONINO L; FRANCIA DI CELLE P
Real time quantitative detection of WT1 gene transcript in acute myeloid leukemia
2006-01-01 RIERA L; SISMONDI F; CHIUSA L; CERETTO C; CAMPISI P; MARMONT F; PICH A; FRANCIA DI CELLE P
p130Cas mediates the transforming properties of the anaplastic lymphoma kinase
2005-01-01 AMBROGIO C; VOENA C; MANAZZA AD; PIVA R; RIERA L; BARBERIS L; COSTA C; TARONE G; DEFILIPPI P; HIRSCH E; ERBA EB; MOHAMMED S; JENSEN ON; PALESTRO G; INGHIRAMI G; CHIARLE R.
Evidence that the Human Cytomegalovirus 46 kDa UL72 protein is not an active dUTPase but a late protein dispensable for replication in fibroblasts
2004-01-01 CAPOSIO P; RIERA L; HAHN G; LANDOLFO S.; GRIBAUDO G
Human cytomegalovirus requires cellular deoxycytidylate deaminase for replication in quiescent cells.
2003-01-01 G. GRIBAUDO; RIERA L; CAPOSIO P; MALEY F; LANDOLFO S
Human cytomegalovirus infection induces cellular thymidylate synthase gene expression in quiescent fibroblasts.
2002-01-01 G. GRIBAUDO; L. RIERA; T.L. RUDGE; P. CAPOSIO; L.F. JOHNSON; S. LANDOLFO
Control of murine cytomegalovirus replication in salivary glands during acute infection is independent of the Fas ligand/Fas system.
2001-01-01 RIERA L; GARIGLIO M; PAGANO M; GAIOLA O; SIMON MM; S. LANDOLFO
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Core binding factor acute myeloid leukaemia and c-KIT mutations | 2013 | Ludovica Riera; Filippo Marmont; Daniela Toppino; Chiara Frairia; Francesca Sismondi; Ernesta Audisio; Cristiana Di Bello; Stefano D'Ardia; Paola Francia Di Celle; Emanuela Messa; Giorgio Inghirami; Umberto Vitolo; Achille Pich | |
| Core binding factor acute myeloid leukemia and c-kit mutations | 2012 | Pich A; Riera L; Frairia C; Toppino D; Audisio E; Sismondi F; D’Ardia S; Di Bello C; Messa E; Francia di Celle P; Marmont F; Inghirami G; Vitolo U | |
| JAK2V617F mutation and allele burden are associated with distinct clinical and morphological subtypes in patients with essential thrombocythaemia | 2012 | Pich A; Riera L; Beggiato E; Nicolino B; Godio L; Campisi P; Sismondi F; Francia di Celle P. | |
| JAK2V617F mutation and allele burden in patients with essential thrombocythemia | 2011 | PICH A; RIERA L; BEGGIATO E; NICOLINO B; GODIO L; CAMPISI P; FRANCIA DI CELLE P. | |
| Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects. | 2011 | Riera L; Lasorsa E; Bonello L; Sismondi F; Tondat F; Di Bello C; Francia di Celle P; Chiarle R; Godio L; Pich A; Facchetti F; Ponzoni M; Marmont F; Zanon C; Bardelli A; Inghirami G. | |
| JAK2V617F MUTATIONAL STATUS IS ASSOCIATED WITH DIFFERENT PHENOTYPES IN ESSENTIAL TROMBOCYTHEMIA | 2010 | Pich A; Riera L; Godio L; Sismondi F; Francia di Celle P | |
| Unveiling the pathogenetic role of Stat3 in human lymphoma | 2010 | Piva R; Pellegrino E; Ferreri C; Cuccuru G; Boccalatte F; Compagno M; Riera L; Cantarella D; Medico E; Agnelli L; Neri A;Di Cunto F; Provero P; Inghirami G | |
| JAK2V617F mutation and allele burden: correlation with morphologic and clinical features and response to therapy in patients with essential thrombocytemia. | 2010 | L. Riera L; Sismondi F; Tondat F; Beggiato E; Schinco P; Nicolino B; Godio L; Francia di Celle P; Pich A. | |
| Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth. | 2010 | Riera L; Lasorsa E; Ambrogio C; Surrenti N; Voena C; Chiarle R. | |
| Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene | 2010 | Barbieri I; Quaglino E; Maritano D; Pannellini T; Riera L; Cavallo F; Forni G; Musiani P; Chiarle R; Poli V. | |
| NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells | 2009 | Ambrogio C; Martinengo C; Voena C; Tondat F; Riera L; di Celle PF; Inghirami G; Chiarle R. | |
| The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL | 2009 | Boccalatte FE; Voena C; Riganti C; Bosia A; D'Amico L; Riera L; Cheng M; Ruggeri B; Jensen ON; Goss VL; Lee K; Nardone J; Rush J; Polakiewicz RD; Comb MJ; Chiarle R; Inghirami G | |
| JAK2V617F activating mutation is associated with the myeloproliferative type of chronic myelomonocytic leukaemia | 2009 | Pich A; Riera L; Sismondi F; Godio L; Davico Bonino L; Marmont F; Francia di Celle P. | |
| JAK2 V617F activating mutation in chronic myelomonocytic leukemia | 2008 | PICH A; RIERA L; SISMONDI F; GODIO L; DAVICO BONINO L; FRANCIA DI CELLE P | |
| Real time quantitative detection of WT1 gene transcript in acute myeloid leukemia | 2006 | RIERA L; SISMONDI F; CHIUSA L; CERETTO C; CAMPISI P; MARMONT F; PICH A; FRANCIA DI CELLE P | |
| p130Cas mediates the transforming properties of the anaplastic lymphoma kinase | 2005 | AMBROGIO C; VOENA C; MANAZZA AD; PIVA R; RIERA L; BARBERIS L; COSTA C; TARONE G; DEFILIPPI P; HIRSCH E; ERBA EB; MOHAMMED S; JENSEN ON; PALESTRO G; INGHIRAMI G; CHIARLE R. | |
| Evidence that the Human Cytomegalovirus 46 kDa UL72 protein is not an active dUTPase but a late protein dispensable for replication in fibroblasts | 2004 | CAPOSIO P; RIERA L; HAHN G; LANDOLFO S.; GRIBAUDO G | |
| Human cytomegalovirus requires cellular deoxycytidylate deaminase for replication in quiescent cells. | 2003 | G. GRIBAUDO; RIERA L; CAPOSIO P; MALEY F; LANDOLFO S | |
| Human cytomegalovirus infection induces cellular thymidylate synthase gene expression in quiescent fibroblasts. | 2002 | G. GRIBAUDO; L. RIERA; T.L. RUDGE; P. CAPOSIO; L.F. JOHNSON; S. LANDOLFO | |
| Control of murine cytomegalovirus replication in salivary glands during acute infection is independent of the Fas ligand/Fas system. | 2001 | RIERA L; GARIGLIO M; PAGANO M; GAIOLA O; SIMON MM; S. LANDOLFO |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile